Introduction
AT INVITROCUE, we develop in vitro and in vivo models that improve the efficacy and safety evaluation for new drugs for biotechnology, pharmaceutical and consumer healthcare companies. Our expertise in developing predictive preclinical models helps to reduce the time and cost of product development and minimize the risks of downstream testing.
Features / strengths
•In vitro Immunology Assays
•In vitro Cell Metabolism Assays
•3D Hepatocytes & Immune Cells Co-Culture
•3D Airway Epithelial Model
•Patient-Derived Organoid (PDO)
•Pathway-Centric Drug Discovery
•Safety Assessment
Specification in detail
Service
In vitro and In vivo Preclinical Services
Supporting document
